Skip to main content
J&J to include drug pricing info in TV ads

Johnson & Johnson said it will include the list price of its drugs and their potential out-of-pocket costs in direct-to-consumer television advertisements starting next month. The move makes J&J the first drugmaker to act on the Trump administration's call for drug price transparency in TV ads, and the company's blood thinner Xarelto, which costs around $450 to $540 per month, will be the first TV ad to include pricing details.

Full Story: